Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof
US-2024390298-A1 · Nov 28, 2024 · US
Modulators of the integrated stress pathway
US2025122188A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025122188-A1 |
| Application number | US-202418648195-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 26, 2024 |
| Priority date | May 5, 2016 |
| Publication date | Apr 17, 2025 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
First claim
Opening claim text (preview).
1 .- 62 . (canceled) 63 . A compound, wherein the compound is or a pharmaceutically acceptable salt thereof. 64 . The compound of claim 63 , wherein the compound is 65 . The compound of claim 63 , wherein the compound is a pharmaceutically acceptable salt of
Assignees
Inventors
Classifications
for myasthenia gravis · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
- A61K31/44Primary
Non condensed pyridines; Hydrogenated derivatives thereof · CPC title
the bicyclo ring system containing eight carbon atoms · CPC title
- C07D471/04Primary
Ortho-condensed systems · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2025122188A1 cover?
- Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
- Who is the assignee on this patent?
- Calico Life Sciences Llc, Abbvie Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/44. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Apr 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).